Clinical Trial Update: Study of GW685698X In Patients With Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 trial update for GW685698X in patients with seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• GW685698X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED